Tap here to turn on desktop notifications to get the news sent straight to you.
Senators Question Rudy Giuliani's Role In Purdue Pharma Opioid Plea Deal
They want to determine if Giuliani firm's $1 million contract with the DOJ as he represented OxyContin company resulted in "unduly lenient treatment."
Yahoo News photo Illustration photos: AP Getty
Malady Mongers: How Drug Companies Sell Treatments By Inventing Diseases
By Michael Walsh, Yahoo News
The marketing strategy behind disease mongering is to link a disease with a drug.
A&J Fotos via Getty Images
The Right-To-Try Bill Puts Patients At Risk In The Name Of Helping Them
Nicole Van Groningen
, Guest Writer
The real gatekeepers to experimental drugs are the pharmaceutical companies, not the FDA.
NurPhoto via Getty Images
Trump's Plan On Prescription Drug Prices Looks Nothing Like What He Promised
So much for an all-out assault on Big Pharma.
Illustration created using Getty Images
Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?
Kaiser Health News
, Editorial Partner
By Emily Kopp, Sydney Lupkin and Elizabeth Lucas Pharmaceutical companies gave at least $116 million to patient advocacy
Spencer Platt via Getty Images
Yep, Martin Shkreli's 5,000 Percent Drug Price Hike Is Still In Effect
Daraprim, used to treat AIDS, malaria and cancer patients, once cost $13.50 a pill. Now it costs $750 a pill.
A Small Town Louisiana Lawsuit Could Pose A Major Threat To Opioid Manufacturers
Using laws written by Napoleon, lawyers in the state are taking on drug makers and distributors, and the suit could potentially overshadow a far bigger federal case.
Amr Alfiky / Reuters
Judge Orders 'Pharma Bro' Martin Shkreli To Forfeit $7.36 Million
The former drug company executive was convicted in 2017 for defrauding investors.
Taws13 via Getty Images
The First Drug For Postpartum Depression Could Be On Its Way
And researchers hope it could treat the condition in days.
George Frey / Reuters
OxyContin Drugmaker Vows To Stop Promoting Opioids To Doctors
Purdue Pharma also said it will cut its sales force by about half.
Do you have info to share with HuffPost reporters?
Jason Reed / Reuters
New Combo HIV Medication Approved By FDA Prompts A Lawsuit
By Deena Beasley, Reuters
Sales of Biktarvy are expected to be about $1 billion this year.
FDA Releases Kratom Death Data, Undermines Its Own Claims About Drug's Deadly Harms
The cases include a suicide and a drug overdose victim who tested positive for nine different substances.
Sophie Quinton, The Pew Charitable Trusts
This Extract Is Driving A Hemp Gold Rush. But Is It Legal?
, Editorial Partner
The federal government is divided on whether the hemp CBD extract is legal.
Molly Ferguson for STAT
Women Need Answers On Drug Use During Pregnancy. Here’s How To Improve Research
Reporting from the frontiers of health and medicine.
By Megan Thielking For decades, it’s been taboo to test medications on pregnant women. But doctors, patients, and public
CVS Pharmacy Buys Up Aetna Insurance In Latest Consolidation Of Pharmaceutical Power
Echols Scholar at the University of Virginia
How is it legal for the company that sells me my meds to own the company that is supposed to help me afford them?
Shannon Stapleton / Reuters
CVS Agrees To Buy Aetna In A $69 Billion Deal
By Carl O'Donnell and Greg Roumeliotis, Reuters
Aetna Inc’s board of directors approved the deal on Sunday, for approximately $207 per share in cash and stock.
More Employers Offering Fertility Benefits Means Happier Employees Who Stay
Dr. David Adamson
Founder and CEO, ARC Fertility
There’s encouraging news for employees who may be facing the challenges of infertility: more employers – beyond tech companies
Feds Prepare For A New War On Kratom, An Herbal Drug Many Swear By
The DEA had previously tried to ban it. Now the FDA is leading the charge.
art by Jesse Mechanic
The '20-Armed Octopus': Deconstructing The Opioid Epidemic
Writer. Founding Editor of TheOvergrown.com
Dr. Abigail Zavod, when speaking about the opioid crisis during a grand rounds presentation at Dartmouth, likened it to a
Brendan McDermid / Reuters
Blaming Inequality On Technology: Sloppy Thinking For The Educated
, Guest Writer
If technology, not policy, is the culprit, it means inequality is something that happened, not something we did.
Adrees Latif / Reuters
Investor Group Presses U.S. Drug Companies On Opioid Controls
By Ross Kerber, Reuters
“We believe these companies have played an important role in this epidemic."
Culture & Arts
TV & Film
Style & Beauty
Food & Drink
Home & Living
Impact: Project Zero
Impact: This New World
Listen to America
FROM OUR PARTNERS
What's Working: Purpose + Profit
The Power of Humanity
Difference Maker 100
Expert analysis and commentary to make sense of today's biggest stories.
Sign up here to have the best stories delivered straight to your inbox.
First-person essays, features, interviews and Q&As about life today.
Get breaking news alerts
Download our app
Go to mobile site